Showing results (261-270 of 632) with videos related to
Sort By:
Pageof 64
American Journal of Respiratory Cell and Molecular Biology|August 1, 1990
Neuropeptide Y (NPY) in human nasal mucosaJ N Baraniuk, S Castellino, J D Lundgren, et al.Journal of Applied Microbiology|December 17, 2009
Characterization of reaerosolization from impingers in an effort to improve airborne virus samplingL Riemenschneider, M-H Woo, C-Y Wu, et al.Clinical Trials (London, England)|June 16, 2006
The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) eraA Mocroft, J Neaton, J Bebchuk, et al.Journal of Neuroimmunology|June 29, 2005
Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitisChristian T Brandt, Jens D Lundgren, Niels Frimodt-Møller, et al.Plos One|September 11, 2014
Potential future impact of a partially effective HIV vaccine in a southern African settingAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.The American Journal of Physiology|February 1, 1990
Calcitonin gene-related peptide in human nasal mucosaJ N Baraniuk, J D Lundgren, J Goff, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|July 30, 2024
Longitudinal importance of the soluble receptor for advanced glycation end-products in nonintubated hospitalized patients with COVID-19 pneumoniaKatherine D Wick, Lianne Siegel, Cathryn Oldmixon, et al.JAMA|November 28, 2001
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral loadA N Phillips, S Staszewski, R Weber, et al.Open Forum Infectious Diseases|June 19, 2019
Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant RecipientsMark P Khurana, Isabelle P Lodding, Amanda Mocroft, et al.The Journal of Infectious Diseases|May 14, 2008
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up, Jens D Lundgren, Abdel Babiker, et al.Pageof 64